NATCO Pharma

BSE : 524816 | NSE : NATCOPHARM

Industry : Pharmaceuticals | ISIN : INE987B01026 | FreeFloat : 45.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)732.92
Net Worth (NW)4,228.70
Intrinsic Worth (IW)4,961.62
Market Cap (MC)16,256.33
Economic Value Added-58.93
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)14.77%
IC Gross Margin (EBITDA/IC)83.95%
IC Net Margin (NPT/IC)50.88%
Knowledge Turnover (Sales/IC)2.50
Market to Intrinsic Value (MC/IW)3.28

As OfIntrinsic ValueMarket Price
30 Sep 2021Rs. 272.11Rs. 891.55
6 Dec 2021 ---- Rs. 832.30
-14.05     -1.69%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 831.07ReduceSell
KB > 50% : No50 DMA : Rs. 858.09
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-18
C
556.70
580.00
231.70
211.00
204.70
159.30
154.30
Mar-19
C
455.70
486.70
179.30
157.60
152.40
120.40
117.00
Jun-19
C
492.30
513.30
212.30
190.30
183.80
142.80
144.50
Sep-19
C
485.70
518.90
167.50
145.60
139.40
117.70
118.60
Dec-19
C
482.20
513.00
159.50
134.10
128.80
104.40
105.00
Mar-20
C
454.80
477.20
150.70
120.20
116.70
93.20
75.50
Jun-20
C
563.40
582.10
189.80
161.80
158.10
122.10
124.20
Sep-20
C
802.20
827.90
302.10
273.40
270.70
203.90
193.30
Dec-20
C
355.20
386.00
113.30
83.50
80.10
63.40
67.00
Mar-21
C
331.30
359.70
104.60
74.20
70.70
53.00
53.90
Jun-21
C
410.30
427.30
126.80
93.00
91.00
75.00
73.00
Sep-21
C
377.20
415.20
108.50
73.80
69.80
65.10
60.60
* C - Consolidated, S - Standalone